Alpha-antitrypsin (Arriva/Hyland Immuno/Protease Sciences)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAlpha-antitrypsin (Arriva/Hyland Immuno/Protease Sciences)

Drug Alias NameInhaled rAAT - Arriva/Hyland Immuno/Protease SciencesAlpha-1 antitrypsin - Arriva/Hyland Immuno/Protease SciencesAlpha-antitrypsin (AAT)- Arriva/Hyland Immuno/Protease SciencesAlpha-1 proteinase inhibitor - Arriva/Hyland Immuno/Protease SciencesrAAT - Arriva/Hyland Immuno/Protease Sciences

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionHIV protease inhibitorsLeukocyte elastase inhibitorsSerine protease inhibitors

TargetsSerine proteaseLeukocyte elastaseHIV protease

Therapy Area/IndicationsEmphysema

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBaxter International Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBaxter International Inc

Active IndicationsN/A

Inactive IndicationsEmphysema

Other Information

ATC CodeN/A